|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 23280 |
FusionGeneSummary for NAA25_FMR1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: NAA25_FMR1 | Fusion gene ID: 23280 | Hgene | Tgene | Gene symbol | NAA25 | FMR1 | Gene ID | 80018 | 2332 |
| Gene name | N(alpha)-acetyltransferase 25, NatB auxiliary subunit | fragile X mental retardation 1 | |
| Synonyms | C12orf30|MDM20|NAP1 | FMRP|FRAXA|POF|POF1 | |
| Cytomap | 12q24.13 | Xq27.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | N-alpha-acetyltransferase 25, NatB auxiliary subunitN-terminal acetyltransferase B complex subunit NAA25mitochondrial distribution and morphology 20natB complex subunit MDM20 | synaptic functional regulator FMR1fragile X mental retardation protein 1 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q14CX7 | Q06787 | |
| Ensembl transtripts involved in fusion gene | ENST00000261745, | ENST00000218200, ENST00000370471, ENST00000370477, ENST00000334557, ENST00000439526, ENST00000370475, ENST00000370470, ENST00000440235, ENST00000492846, | |
| Fusion gene scores | * DoF score | 5 X 5 X 5=125 | 3 X 3 X 1=9 |
| # samples | 5 | 3 | |
| ** MAII score | log2(5/125*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: NAA25 [Title/Abstract] AND FMR1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | FMR1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 18653529 |
| Tgene | FMR1 | GO:0002092 | positive regulation of receptor internalization | 25561520 |
| Tgene | FMR1 | GO:0006974 | cellular response to DNA damage stimulus | 24813610 |
| Tgene | FMR1 | GO:0033129 | positive regulation of histone phosphorylation | 24813610 |
| Tgene | FMR1 | GO:0045727 | positive regulation of translation | 19097999|19166269 |
| Tgene | FMR1 | GO:0051489 | regulation of filopodium assembly | 16631377 |
| Tgene | FMR1 | GO:0060998 | regulation of dendritic spine development | 16631377 |
| Tgene | FMR1 | GO:0098586 | cellular response to virus | 24514761 |
| Tgene | FMR1 | GO:0098908 | regulation of neuronal action potential | 25561520 |
| Tgene | FMR1 | GO:1902416 | positive regulation of mRNA binding | 25464849 |
| Tgene | FMR1 | GO:2000637 | positive regulation of gene silencing by miRNA | 17057366 |
| Tgene | FMR1 | GO:2001022 | positive regulation of response to DNA damage stimulus | 24813610 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AW801819 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000261745 | ENST00000218200 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
| intron-3UTR | ENST00000261745 | ENST00000370471 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
| intron-3UTR | ENST00000261745 | ENST00000370477 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
| intron-intron | ENST00000261745 | ENST00000334557 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
| intron-3UTR | ENST00000261745 | ENST00000439526 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
| intron-3UTR | ENST00000261745 | ENST00000370475 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
| intron-intron | ENST00000261745 | ENST00000370470 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
| intron-intron | ENST00000261745 | ENST00000440235 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
| intron-intron | ENST00000261745 | ENST00000492846 | NAA25 | chr12 | 112488811 | - | FMR1 | chrX | 147030915 | + |
Top |
FusionProtFeatures for NAA25_FMR1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| NAA25 | FMR1 |
| Non-catalytic subunit of the NatB complex whichcatalyzes acetylation of the N-terminal methionine residues ofpeptides beginning with Met-Asp-Glu. May play a role in normalcell-cycle progression. {ECO:0000269|PubMed:18570629}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NAA25_FMR1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NAA25_FMR1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NAA25_FMR1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NAA25_FMR1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | FMR1 | C0016667 | Fragile X Syndrome | 9 | CTD_human;ORPHANET;UNIPROT |
| Tgene | FMR1 | C0004352 | Autistic Disorder | 5 | CTD_human;HPO |
| Tgene | FMR1 | C0036341 | Schizophrenia | 2 | PSYGENET |
| Tgene | FMR1 | C0041696 | Unipolar Depression | 2 | PSYGENET |
| Tgene | FMR1 | C0376634 | Craniofacial Abnormalities | 2 | CTD_human |
| Tgene | FMR1 | C1269683 | Major Depressive Disorder | 2 | PSYGENET |
| Tgene | FMR1 | C3714756 | Intellectual Disability | 2 | CTD_human |
| Tgene | FMR1 | C0000768 | Congenital Abnormality | 1 | CTD_human |
| Tgene | FMR1 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
| Tgene | FMR1 | C0009241 | Cognition Disorders | 1 | CTD_human |
| Tgene | FMR1 | C0018051 | Gonadal Dysgenesis | 1 | CTD_human |
| Tgene | FMR1 | C0086132 | Depressive Symptoms | 1 | PSYGENET |
| Tgene | FMR1 | C0282631 | Facies | 1 | CTD_human |
| Tgene | FMR1 | C0338908 | Mixed anxiety and depressive disorder | 1 | PSYGENET |
| Tgene | FMR1 | C0525045 | Mood Disorders | 1 | PSYGENET |
| Tgene | FMR1 | C1839780 | FRAGILE X TREMOR/ATAXIA SYNDROME | 1 | CTD_human;ORPHANET |
| Tgene | FMR1 | C2678248 | Mood instability | 1 | PSYGENET |
| Tgene | FMR1 | C2749127 | Primary Ovarian Insufficiency, Fragile X-Associated | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|